Written Question·Department of Health and Social Care·UIN 16574
Fezolinetant
Tabled: 7 July 2026
Answered: 15 July 2026
Question
Dr Luke Evans
Conservative — Hinckley and Bosworth
To ask the Secretary of State for Health and Social Care, whether he has had discussions with NHS England on access to fezolinetant within Leicester, Leicestershire and Rutland Integrated Care Board.
Answer
Preet Kaur GillThe National Institute for Health and Care Excellence (NICE) published guidance on 31 March 2026 recommending fezolinetant as an option for treating moderate to severe menopause-related hot flushes and night sweats when hormone replacement therapy is unsu...
ⓘ
This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 16574) →